Karen L. Kosar

FDA investigator

Appears on 4 documents from 2013 to 2019, mostly at sites in New York. Most often cites control of microbiological contamination (21 CFR 211.113).

4
Documents on file
7.8
Observations per 483
2013
First seen
2019
Most recent

What they cite most

From 31 observations

Activity by year

2013: 2, 2016: 1, 2019: 1

Where

New York 4

Often inspects with

James A. Liubicich· Omadevi Somai

Is Karen L. Kosar coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

4 documents, newest first
FirmOpen
483 Jerome Stevens Pharmaceuticals, Inc.Apr 11, 2019 · Bohemia, New York
483 Pine Pharmacy and Home Care Products Center Inc.Apr 18, 2016 · Williamsvil le, New York
483 Pine Pharmacy and Home Care Products Center, IncDec 16, 2013 · Williamsvil le, New York
483 Pine Pharmacy and Home Care Products Center, Inc.Jul 19, 2013 · Williamsvil le, New York

About this profile

What does Karen L. Kosar inspect?

Karen L. Kosar appears on 4 documents on file covering 2 sites, mostly in New York.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.166 and 21 CFR 211.42.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Karen L. Kosar is dated Apr 11, 2019.